EUVIMEDEUVIMED entdecken
Crossref

Liver Transplantation for Primary Sclerosing Cholangitis: A 20-Year Single-Center Experience

Sinan Efe Yazıcı, Ahmet Atasever, Şencan Acar, Yıldıray Yuzer

Hitit Medical Journal · 29.06.2026 · 8 (2) · 360-368

DOI: 10.52827/hititmedj.1884545 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hitit Medical Journal, online erschienen am 29.06.2026. Verfasst von Sinan Efe Yazıcı und 3 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben. Gefördert von: No supporting institution or financial support was received for this study..

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective:Primary sclerosing cholangitis is a chronic, progressive cholestatic liver disease that frequently leads to liver transplantation. Although liver transplantation remains the only definitive treatment for advanced disease, post-transplant recurrence may adversely influence long-term outcomes. This study aimed to evaluate recurrence rates and clinical outcomes after liver transplantation in patients with primary sclerosing cholangitis.Matherial and Methods:This retrospective single-center study included thirty-seven patients who underwent liver transplantation between December 2004 and April 2025 due to primary sclerosing cholangitis. Demographic characteristics, clinical findings, surgical approaches, medical treatments, complications, recurrence patterns, and survival outcomes were evaluated using descriptive statistical methods.Results:The cohort consisted of sixteen males and twenty-one females with a mean age of 41.9 years at the time of transplantation. The mean disease duration was 6.1 years and the mean Model for End-Stage Liver Disease score was 18.4. Inflammatory bowel disease was present in 43 percent of patients, all diagnosed with ulcerative colitis. Living donor liver transplantation was performed in thirty-six patients, while one patient received a deceased donor graft. Incidental cholangiocarcinoma was identified in two explanted livers. During follow-up, disease recurrence developed in nine patients at a mean of 45.6 months, and two patients required re-transplantation. Five-year mortality was 13.5 percent, with three deaths associated with recurrence and related complications.Conclusion:Liver transplantation provides favorable long-term survival in patients with primary sclerosing cholangitis; however, recurrence remains a significant challenge. Structured long-term surveillance, optimized medical management, and multidisciplinary follow-up are essential to improve post-transplant outcomes.

Förderung

  • No supporting institution or financial support was received for this study.

Zitieren

APA

Yazıcı, S. E., Atasever, A., Acar, Ş., & Yuzer, Y. (2026). Liver Transplantation for Primary Sclerosing Cholangitis: A 20-Year Single-Center Experience. Hitit Medical Journal, 8(2), 360-368. https://doi.org/10.52827/hititmedj.1884545

Vancouver

Yazıcı SE, Atasever A, Acar Ş, Yuzer Y. Liver Transplantation for Primary Sclerosing Cholangitis: A 20-Year Single-Center Experience. Hitit Medical Journal. 2026;8(2):360-368. doi:10.52827/hititmedj.1884545

BibTeX
@article{Yazc2026,
  author = {Yazıcı, Sinan Efe and Atasever, Ahmet and Acar, Şencan and Yuzer, Yıldıray},
  title = {Liver Transplantation for Primary Sclerosing Cholangitis: A 20-Year Single-Center Experience},
  journal = {Hitit Medical Journal},
  year = {2026},
  volume = {8},
  number = {2},
  pages = {360--368},
  doi = {10.52827/hititmedj.1884545}
}
Kostenlos starten →